18.86
Schlusskurs vom Vortag:
$18.23
Offen:
$18.19
24-Stunden-Volumen:
82,663
Relative Volume:
0.30
Marktkapitalisierung:
$484.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$11.77M
KGV:
32.60
EPS:
0.5785
Netto-Cashflow:
$-19.23M
1W Leistung:
+1.62%
1M Leistung:
+13.34%
6M Leistung:
+6.92%
1J Leistung:
+22.39%
Tourmaline Bio Inc Stock (TRML) Company Profile
Firmenname
Tourmaline Bio Inc
Sektor
Branche
Telefon
646-481-9832
Adresse
27 WEST 24TH STREET, NEW YORK
Vergleichen Sie TRML mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TRML
Tourmaline Bio Inc
|
18.86 | 476.78M | 0 | 11.77M | -19.23M | 0.5785 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-23 | Eingeleitet | Chardan Capital Markets | Buy |
2025-03-06 | Eingeleitet | Wedbush | Outperform |
2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
2024-11-11 | Bestätigt | H.C. Wainwright | Buy |
2023-12-15 | Eingeleitet | Jefferies | Buy |
2023-12-04 | Fortgesetzt | H.C. Wainwright | Buy |
2023-11-17 | Eingeleitet | Truist | Buy |
2023-10-31 | Eingeleitet | Guggenheim | Buy |
2023-10-25 | Eingeleitet | Piper Sandler | Overweight |
2022-10-20 | Eingeleitet | H.C. Wainwright | Buy |
2022-07-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Tourmaline Bio Inc Aktie (TRML) Neueste Nachrichten
What drives Tourmaline Bio Inc. stock priceMarket-leading profit generation - jammulinksnews.com
Is Tourmaline Bio Inc. a good long term investmentMarket-crushing profits - jammulinksnews.com
Tourmaline Bio Inc. Stock Analysis and ForecastBreakthrough profit margins - jammulinksnews.com
What analysts say about Tourmaline Bio Inc. stockConsistently profitable trades - jammulinksnews.com
What drives SuRo Capital Corp. stock priceRapid wealth multiplication - jammulinksnews.com
High Growth Stocks in India s Emerging Markets Trusted Market PredictionsRapid market gains - Autocar Professional
What drives NMTC stock priceRemarkable growth - jammulinksnews.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of “Buy” from Brokerages - Defense World
What analysts say about TACOU stockPowerful profit generation - Jammu Links News
Is Nuburu Inc. a good long term investmentFree Investment Case Studies - Jammu Links News
What drives Warrior Met Coal Inc. stock priceFree Daily Trading Room Entry - Jammu Links News
Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser
should you buy bull(mumu the bull erc)Free Top Growth Stock Recommendations - Newser
Why Tourmaline Bio Inc. stock attracts strong analyst attentionDouble Your Capital Alerts - Newser
How Tourmaline Bio Inc. stock performs during market volatilityFree Discussion Group - Newser
What makes Tourmaline Bio Inc. stock price move sharplyCarefully Curated High Return Stocks - Newser
What makes Universe Pharmaceuticals INC stock price move sharplyInsider Level Guidance - Newser
How Cross Country Healthcare Inc. stock performs during market volatilitySafe High Return Entry Points - Newser
How Orange County Bancorp Inc. stock performs during market volatilityDouble Profit With Half Risk - Newser
What makes Synopsys Inc. stock price move sharplyPro Trader Stock Focus - Newser
Why XRLX stock attracts strong analyst attentionFree Stock Trading Signals - Newser
How KRON stock performs during market volatilityVerified Return Tips - Newser
How Cantor Equity Partners Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser
Graves Ophthalmopathy Market Set to Grow Substantially Through 2034, DelveInsight Projects | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited - Barchart.com
Avrupa Minerals (CVE:AVU) Trading 33.3% Higher – What’s Next? - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by California State Teachers Retirement System - Defense World
Cantor Fitzgerald Weighs in on Tourmaline Bio FY2026 Earnings - Defense World
Finanzdaten der Tourmaline Bio Inc-Aktie (TRML)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):